These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7592511)

  • 1. Plasma clozapine levels and clinical benefit.
    Greenberg WM
    J Clin Psychiatry; 1995 Nov; 56(11):535-6. PubMed ID: 7592511
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.
    Potkin SG; Bera R; Gulasekaram B; Costa J; Hayes S; Jin Y; Richmond G; Carreon D; Sitanggan K; Gerber B
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():133-6. PubMed ID: 7961557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.
    Miller DD; Fleming F; Holman TL; Perry PJ
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():117-21. PubMed ID: 7961554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine concentrations and clinical response in schizophrenic patients.
    Owen JA; Delva NJ; Lawson JS
    Am J Psychiatry; 1992 Aug; 149(8):1120-1. PubMed ID: 1636820
    [No Abstract]   [Full Text] [Related]  

  • 5. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I; Levine S
    Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
    [No Abstract]   [Full Text] [Related]  

  • 6. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood clozapine level and therapeutic adjustment].
    Préterre P
    Encephale; 1995 Jun; 21 Spec No 3():53-7. PubMed ID: 7628343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of determining clozapine plasma level in follow-up of schizophrenic patients].
    Vailleau JL; Jeanny B; Chomard P; Vincent R
    Encephale; 1996; 22(2):103-9. PubMed ID: 8706619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine decreases smoking in patients with chronic schizophrenia.
    McEvoy J; Freudenreich O; McGee M; VanderZwaag C; Levin E; Rose J
    Biol Psychiatry; 1995 Apr; 37(8):550-2. PubMed ID: 7619979
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.
    Piscitelli SC; Frazier JA; McKenna K; Albus KE; Grothe DR; Gordon CT; Rapoport JL
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.
    Wong JO; Leung SP; Mak T; Ng RM; Chan KT; Hon-Kee Cheung H; Choi WK; Lai J; Wai-Kiu Tsang A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):251-64. PubMed ID: 16316716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine in the treatment of a young adolescent with schizophrenia.
    Jacobsen LK; Walker MC; Edwards JE; Chappell PB; Woolston JL
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):645-50. PubMed ID: 8056727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Schizophrenia, affective symptoms and clozapine].
    Meynard JA; Bernadet R; Sanchez MF; Morel P
    Encephale; 1995 Jun; 21 Spec No 3():41-7. PubMed ID: 7628341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
    Schulz E; Remschmidt H; Fleischhaker C
    Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):285-98. PubMed ID: 7856324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term clinical experience with clozapine].
    Gelly F; Chambon O; Marie-Cardine M
    Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.
    Perry PJ; Miller DD; Arndt SV; Cadoret RJ
    Am J Psychiatry; 1991 Feb; 148(2):231-5. PubMed ID: 1670979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of neuroleptic therapy in the self assessment of schizophrenic patients].
    Heim M
    Psychiatr Neurol Med Psychol (Leipz); 1987 Aug; 39(8):487-91. PubMed ID: 3685210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the therapeutic window: a case presentation.
    Schulz SC; Butterfield L; Garicano M; Narasimhachari N; Friedel RO
    J Clin Psychiatry; 1984 May; 45(5):223-5. PubMed ID: 6725212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of neurological signs with clozapine treatment.
    Buchanan RW; Koeppl P; Breier A
    Biol Psychiatry; 1994 Aug; 36(3):198-200. PubMed ID: 7948457
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state.
    Jibiki I; Kubota T; Fujimoto K; Sakamoto H; Hasegawa M; Furuta H; Yamaguchi N
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.